Skip to content

Clinical trials

Phase 3 Atherosclerosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 3 Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20081
20091
20101
20111
20122
20161
20181
20222
20242
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
GlaxoSmithKline3
Amgen2
AstraZeneca2
Novartis Pharmaceuticals2
AtheroMed, Inc1
CSL Behring1
Esperion Therapeutics, Inc.1
Ludwig-Maximilians - University of Munich1
NewAmsterdam Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis19
Cardiovascular Diseases7
Heart Diseases4
Peripheral Arterial Disease4
Coronary Disease3
Acute Coronary Syndrome2
Cerebrovascular Disorders2
Coronary Artery Disease2
Hypercholesterolemia2
Stroke2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.